{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T03:07:16Z","timestamp":1792292836817,"version":"4.4.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,18]],"date-time":"2023-06-18T00:00:00Z","timestamp":1687046400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007819","name":"Allergan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006545","name":"National Institute on Minority Health and Health Disparities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006545","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Glaucoma"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.ogla.2023.06.007","type":"journal-article","created":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T21:25:42Z","timestamp":1687209942000},"page":"599-608","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Single Administration of Bimatoprost Implant"],"prefix":"10.1016","volume":"6","author":[{"given":"Robert N.","family":"Weinreb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Christie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe A.","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Randy","family":"Craven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimmie","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Bejanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Wirta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ogla.2023.06.007_bib1","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1097\/IJG.0b013e3182a0762f","article-title":"Postural change in intraocular pressure: a comparison of measurement with a Goldmann tonometer, Tonopen XL, pneumatonometer, and HA-2","volume":"23","author":"Barkana","year":"2014","journal-title":"J\u00a0Glaucoma"},{"key":"10.1016\/j.ogla.2023.06.007_bib2","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.survophthal.2019.09.004","article-title":"Review of the measurement and management of 24-hour intraocular pressure in patients with glaucoma","volume":"65","author":"Mansouri","year":"2020","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ogla.2023.06.007_bib3","first-page":"2912","article-title":"Twenty-four\u2013hour pattern of intraocular pressure in the aging population","volume":"40","author":"Liu","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ogla.2023.06.007_bib4","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1167\/iovs.02-0666","article-title":"Twenty-four-hour intraocular pressure pattern associated with early glaucomatous changes","volume":"44","author":"Liu","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ogla.2023.06.007_bib5","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1167\/iovs.12-10709","article-title":"Twenty-four\u2013hour pattern of intraocular pressure in untreated patients with ocular hypertension","volume":"54","author":"Grippo","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ogla.2023.06.007_bib6","article-title":"Estimation of 24-hour intraocular pressure peak timing and variation using a contact lens sensor","volume":"10","author":"Liu","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ogla.2023.06.007_bib7","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.3109\/02713683.2015.1098707","article-title":"Expression of lipid peroxidation markers in the tear film and ocular surface of patients with non-Sjogren syndrome: potential biomarkers for dry eye disease","volume":"41","author":"Choi","year":"2016","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.ogla.2023.06.007_bib8","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/archopht.124.6.793","article-title":"Clinical utility of intraocular pressure monitoring outside of normal office hours in patients with glaucoma","volume":"124","author":"Barkana","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ogla.2023.06.007_bib9","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/ICU.0b013e32831eef4f","article-title":"Intraocular pressure measurements throughout the 24 h","volume":"20","author":"Bagga","year":"2009","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.ogla.2023.06.007_bib10","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ajo.2004.04.022","article-title":"Comparison of the nocturnal effects of once-daily timolol and latanoprost on intraocular pressure","volume":"138","author":"Liu","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ogla.2023.06.007_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0140601","article-title":"Effects of topical bimatoprost 0.01% and timolol 0.5% on circadian IOP, blood pressure and perfusion pressure in patients with glaucoma or ocular hypertension: a randomized, double masked, placebo-controlled clinical trial","volume":"10","author":"Oddone","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ogla.2023.06.007_bib12","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.ajo.2006.01.049","article-title":"Sustained effect of travoprost on diurnal and nocturnal intraocular pressure","volume":"141","author":"Sit","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ogla.2023.06.007_bib13","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ophtha.2005.10.045","article-title":"Comparison of the effects of latanoprost, travoprost, and bimatoprost on circadian intraocular pressure in patients with glaucoma or ocular hypertension","volume":"113","author":"Orzalesi","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2023.06.007_bib14","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/IJG.0b013e318133fb70","article-title":"The effect of latanoprost, bimatoprost, and travoprost on circadian variation of intraocular pressure in patients with open-angle glaucoma","volume":"17","author":"Yildirim","year":"2008","journal-title":"J\u00a0Glaucoma"},{"key":"10.1016\/j.ogla.2023.06.007_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-001106","article-title":"Twenty-four-hour effects of bimatoprost 0.01% monotherapy on intraocular pressure and ocular perfusion pressure","volume":"2","author":"Tung","year":"2012","journal-title":"BMJ Open"},{"key":"10.1016\/j.ogla.2023.06.007_bib16","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.ophtha.2020.06.018","article-title":"Phase 3, randomized, 20-month study of bimatoprost implant in open-angle glaucoma and ocular hypertension (ARTEMIS 1)","volume":"127","author":"Medeiros","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2023.06.007_bib17","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1007\/s11095-010-0159-x","article-title":"Biodegradable implants for sustained drug release in the eye","volume":"27","author":"Lee","year":"2010","journal-title":"Pharm Res"},{"key":"10.1016\/j.ogla.2023.06.007_bib18","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1007\/s40265-021-01624-9","article-title":"Phase 3, randomized, 20-month study of the efficacy and safety of bimatoprost implant in patients with open-angle glaucoma and ocular hypertension (ARTEMIS 2)","volume":"81","author":"Bacharach","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.ogla.2023.06.007_bib19","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ajo.2016.11.020","article-title":"Bimatoprost sustained-release implants for glaucoma therapy: 6-month results from a phase I\/II clinical trial","volume":"175","author":"Lewis","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ogla.2023.06.007_bib20","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1136\/bjophthalmol-2013-304064","article-title":"Bimatoprost 0.03%\/timolol 0.5% preservative-free ophthalmic solution versus bimatoprost 0.03%\/timolol 0.5% ophthalmic solution (Ganfort) for glaucoma or ocular hypertension: a 12-week randomised controlled trial","volume":"98","author":"Goldberg","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ogla.2023.06.007_bib21","first-page":"123","article-title":"Intraocular pressure fluctuation and the risk of glaucomatous damage deterioration: a meta-analysis","volume":"12","author":"Guo","year":"2019","journal-title":"Int J Ophthalmol"},{"key":"10.1016\/j.ogla.2023.06.007_bib22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1089\/jop.2009.0124","article-title":"Meta-analysis of 24-h intraocular pressure fluctuation studies and the efficacy of glaucoma medicines","volume":"26","author":"Stewart","year":"2010","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"key":"10.1016\/j.ogla.2023.06.007_bib23","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ogla.2019.07.006","article-title":"Reproducibility of 5 methods of ocular tonometry","volume":"2","author":"Kutzscher","year":"2019","journal-title":"Ophthalmol Glaucoma"},{"key":"10.1016\/j.ogla.2023.06.007_bib24","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1442-9071.2006.01266.x","article-title":"Effects of central corneal thickness and corneal curvature on the intraocular pressure measurement by Goldmann applanation tonometer and ocular blood flow pneumatonometer","volume":"34","author":"Saleh","year":"2006","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.ogla.2023.06.007_bib25","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s40265-019-01248-0","article-title":"24-Month phase I\/II clinical trial of bimatoprost sustained-release implant (Bimatoprost SR) in glaucoma patients","volume":"80","author":"Craven","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.ogla.2023.06.007_bib26","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1089\/jop.2018.0095","article-title":"Dose-response of intracameral bimatoprost sustained-release implant and topical bimatoprost in lowering intraocular pressure","volume":"35","author":"Lee","year":"2019","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"key":"10.1016\/j.ogla.2023.06.007_bib27","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1089\/jop.2019.0146","article-title":"Matrix metalloproteinases and glaucoma treatment","volume":"36","author":"Weinreb","year":"2020","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"key":"10.1016\/j.ogla.2023.06.007_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/ICO.0b013e31815892da","article-title":"Review of corneal endothelial specular microscopy for FDA clinical trials of refractive procedures, surgical devices, and new intraocular drugs and solutions","volume":"27","author":"McCarey","year":"2008","journal-title":"Cornea"},{"key":"10.1016\/j.ogla.2023.06.007_bib29","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3892\/etm.2021.11052","article-title":"Risk factors for fluctuations in corneal endothelial cell density (review)","volume":"23","author":"Vaiciuliene","year":"2022","journal-title":"Exp Ther Med"}],"container-title":["Ophthalmology Glaucoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589419623001096?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589419623001096?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T18:53:58Z","timestamp":1762887238000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589419623001096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S2589419623001096"],"URL":"https:\/\/doi.org\/10.1016\/j.ogla.2023.06.007","relation":{},"ISSN":["2589-4196"],"issn-type":[{"value":"2589-4196","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single Administration of Bimatoprost Implant","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Glaucoma","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ogla.2023.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}